Actual Medicinal Product (AMP) Imipramine 25mg tablets (Medihealth (Northern) Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Imipramine hydrochloride turns yellowish or reddish on exposure to light. Store in airtight containers and protect from moisture and light.
- Provenance
-
This compatibility recommendation is derived from Imipramine 25mg tablets (Accord Healthcare Ltd).
- Generic
- Imipramine
- Formulation
- Imipramine 25mg tablets
-
Imipramine
-
Imipramine 25mg tablets
-
Imipramine 25mg tablets (Medihealth (Northern) Ltd)
-
-